Dysfunctional high-density lipoprotein: not only quantity but first of all quality?

被引:8
作者
Agouridis, Aris P. [1 ,2 ]
Banach, Maciej [3 ]
Mikhailidis, Dimitri P. [4 ]
机构
[1] Univ Ioannina, Sch Med, Dept Internal Med, GR-45110 Ioannina, Greece
[2] Royal Free London Fdn Trust, Dept Clin Biochem, Vasc Dis Prevent Clin, London, England
[3] Med Univ Lodz, Chair Nephrol & Hypertens, Dept Hypertens, Lodz, Poland
[4] UCL, Dept Clin Biochem, Vasc Dis Prevent Clin, Sch Med, London NW3 2QG, England
关键词
HDL; SUBPOPULATIONS; CHOLESTEROL; DRUGS;
D O I
10.5114/aoms.2015.49816
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:230 / 231
页数:2
相关论文
共 13 条
[1]   Prevalence of low high-density lipoprotein cholesterol (HDL-C) as a marker of residual cardiovascular risk among acute coronary syndrome patients from Oman [J].
Al-Zakwani, Ibrahim ;
Sulaiman, Kadhim ;
Al-Rasadi, Khalid ;
Mikhailidis, Dimitri P. .
CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (04) :879-885
[2]   INVESTIGATING DYSFUNCTIONAL-HDL IN SELECTED GROUPS OF PATIENTS AT HIGH RISK OF CARDIOVASCULAR EVENTS (DYS-HDL STUDY) - PROTOCOL AND ORGANIZATION [J].
Banach, M. ;
Rysz, J. ;
Rizzo, M. ;
Otvos, J. ;
Toth, P. P. ;
Pencina, M. J. ;
Mlynarski, W. ;
Mikhailidis, D. P. .
ATHEROSCLEROSIS, 2014, 235 (02) :E171-E172
[3]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[4]   Carotid intima media thickness and low high-density lipoprotein (HDL) in South Asian immigrants: could dysfunctional HDL be the missing link? [J].
Dodani, Sunita ;
Dong, Lei ;
Guirgis, Faheem W. ;
Reddy, Srinivasa T. .
ARCHIVES OF MEDICAL SCIENCE, 2014, 10 (05) :870-879
[5]   Can We Change the Functionality of HDL Cholesterol with Non-pharmacological and Pharmacological Agents? [J].
Dragan, S. ;
Serban, C. ;
Banach, M. .
CURRENT MEDICINAL CHEMISTRY, 2014, 21 (25) :2927-2946
[6]   Multiple actions of high-density lipoprotein [J].
Florentin, Matilda ;
Liberopoulos, Evangelos N. ;
Wierzbicki, Anthony S. ;
Mikhailidis, Dimitri P. .
CURRENT OPINION IN CARDIOLOGY, 2008, 23 (04) :370-378
[7]   Emerging drugs for hyperlipidaemia: an update [J].
Florentin, Matilda ;
Kostapanos, Michael S. ;
Kei, Anastazia ;
Elisaf, Moses S. .
EXPERT OPINION ON EMERGING DRUGS, 2014, 19 (04) :471-488
[8]  
Gomaraschi M, 2015, HANDB EXP PHARMACOL, V224, P593, DOI 10.1007/978-3-319-09665-0_19
[9]   Effect of Atorvastatin on Low-Density Lipoprotein Subpopulations and Comparison Between Indicators of Plasma Atherogenicity: A Pilot Study [J].
Kucera, Marek ;
Oravec, Stanislav ;
Hirnerova, Eva ;
Huckova, Nada ;
Celecova, Zuzana ;
Gaspar, Ludovit ;
Banach, Maciej .
ANGIOLOGY, 2014, 65 (09) :794-799
[10]   Dysfunctional HDL: A novel important diagnostic and therapeutic target in cardiovascular disease? [J].
Otocka-Kmiecik, Aneta ;
Mikhailidis, Dimitri P. ;
Nicholls, Stephen J. ;
Davidson, Michael ;
Rysz, Jacek ;
Banach, Maciej .
PROGRESS IN LIPID RESEARCH, 2012, 51 (04) :314-324